Work

Abstract PS2-02-20: Treatment patterns and clinical outcomes following progression on first-line ET + CDK4/6i among patients with HR+/HER2− metastatic breast cancer (mBC) in the US

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-02-20

Authors: V. Kaklamani, S. Valliant, S. Hunter, O. Tymejczyk, A. Yu, P. Earla, S. Mehta, E. Pang

Institutions: The University of Texas at San Antonio Health Science Center, Daiichi Sankyo (United States), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129583955

Cites:

Cited by: 1

Related to: